| No |
Author |
Sample |
Arsenic species |
Dose /Exposure |
| 1 |
Gattiet al., 2014 [40] |
non smal cell lung cancer A549 |
Arsenic trioxide |
80µM, 3hrs |
| 2 |
Yooet al., 2009 [41] |
HCC cell line SK-Hep-1 |
Sodium arsenite |
2μM, 48 h |
| 3 |
Yedjou and Tchounwou, 2007 [42] |
HL-60 promyelocyticleukemia cell line |
Arsenic trioxide |
10 μg/mL |
| 4 |
Doppet al., 2008 [43] |
Primary human hepatocytes |
Sodium arsenite/arsenate |
0.1-500μM, 1 hr |
| 5 |
Graham et al., 2014 [44,45] |
Induced plurpotent stem cell (IPS) |
Arsenic trioxide |
1,3,5,7,9µg/ml, 24hrs |
| 6 |
Jan et al., 2006 [46] |
NB4- human promyelocyticleukemia cell line |
Arsenic trioxide |
1μM |
| 7 |
Kryeziuet al., 2013 [47] |
NSCLC cell lines A549 |
Arsenic trioxide |
100µmol/L, 6hrs |
| 8 |
Liu et al., 2010 [48] |
glioblastoma multiforme U87 cells |
Arsenic trioxide |
6μM, 4 h |
| 9 |
Nakamura et al., 2013 [49] |
osteosarcoma cell line 143B |
Arsenic trioxide |
3µM |
| 10 |
Puet al., 2007 [50] |
NB4-human promyelocyticleukemia cell line |
Sodium arsenite |
0.2μM, 1 h and 24hrs |
| 11 |
Qin et al., 2008 [51] |
human keratinocyte cell line (HaCat) |
Sodium arsenite |
10μM, 24 hrs |
| 12 |
Stevens et al., 2010 [52] |
Human colon cancer (HT-29) |
Arsenic trioxide |
2,4,6,8,10,12 μg/mL, 24 h |
| 13
3 |
Wnecket al., 2011 [53] |
bladder urothelial cells (UROtsa) |
Monomethylarsonous acid |
50 nM, 12 weeks |
| 14 |
Xieet al., 2014 [2] |
lung fibroblast/epithelial cells |
Sodium arsenite |
0.5,1,5,10µM, 24/120hrs |
| 15 |
Chai et al., 2007 [8] |
Human uroepithelial cell line (SV-HUC-1) |
Sodium arsenite |
1, 2, 4, 8, 10 μM, 48hrs |
|
